- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07932171
Carotid Ultrasound-based Assessment of Maternal Hemodynamics to Guide HYpertension Treatment in PREgnancy - Pilot Study (CHYPRE-Pilot)
Carotid ultrasound-based assessment of maternal hemodynamics to guide HYpertension treatment in PREgnancy - Pilot study - CHYPRE-pilot Healthy pregnancy is associated with significant physiological hemodynamic changes that are critical for maternal adaptation and health. Insufficient adaptive changes can lead to pregnancy disorders such as preeclampsia. Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal and foetal morbidity and mortality. Assessment of maternal hemodynamic alterations can improve management strategies by better risk stratification of pregnant women. Current methods for maternal hemodynamic measurement involve transthoracic echocardiography, requiring expert consultation with a cardiologist and highly trained staff. Simpler techniques like carotid ultrasound based hemodynamic assessment can potentially provide an easy-to perform alternative, requiring minimal training.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Aims and objectives of the study Main objective: to evaluate the accuracy of carotid-ultrasound for classifying individuals with very high peripheral vascular resistance (PVR) or not very high PVR during pregnancy, using echocardiography as the standard reference, both performed by an expert operator.
Primary endpoint: The agreement between carotid ultrasound and echocardiography to classify individuals with very high (>1300 dynes.s.cm-5) vs not high (=<1300 dynes.s.cm-5) PVR the day of inclusion. The area under the receiver operating characteristic (AUROC) curve, sensitivity and specificity of carotid ultrasound to identify very high PVR will be calculated.
Secondary objectives:
- To evaluate the agreement between PVR measurements obtained by echocardiography and carotid ultrasound as continuous variables.
- To evaluate the agreement between cardiac output (CO)measurements obtained by echocardiography and carotid ultrasound as continuous variables.
- To evaluate inter-operator agreement and variability in carotid ultrasound measurement of PVR between an expert operator and a novice operator.
- To evaluate inter-operator agreement and variability in carotid ultrasound measurement of CO between an expert operator and a novice operator.
Exploratory objectives:
- To evaluate the association between very high (>1300 dynes.s.cm-5) PVR during pregnancy (defined using carotid ultrasound) with adverse pregnancy outcomes (preeclampsia or pre-term birth).
- To investigate whether the agreement between the PVR obtained by echocardiography and carotid ultrasound is acceptable in both healthy and pathological pregnancies.
- To evaluate the usability of carotid ultrasound in routine maternity setting.
Secondary endpoints:
- Bland Altman analysis to evaluate the agreement between echocardiography and carotid ultrasound-based estimation of PVR on a continuous scale. Mean differences and bias will be calculated.
- Inter-operator variability between expert and novice operator for carotid ultrasound-based PVR measurement using Bland-Altman analysis and Intraclass Correlation Coefficient (ICC) will be performed.
Exploratory endpoints:
- Multivariable logistic regression with the PVR group as exposure and adverse pregnancy outcomes (preeclampsia or pre-term birth) as outcome. Adjusted odds for very high PVR vs normal pregnancy will be calculated.
- Absence of significant bias in the Bland-Altman analysis both in healthy and pathological pregnancies.
- Mean group score from the post experience usability questionnaire.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Océane KACIMI
- Número de telefone: +33140275508
- E-mail: oceane.kacimi@aphp.fr
Estude backup de contato
- Nome: Rosa-Maria Pr BRUNO
- Número de telefone: +33156093991
- E-mail: rosamaria.bruno@aphp.fr
Locais de estudo
-
-
Clamart
-
Clamart, Clamart, França, 92141
- Hôpital Antoine Béclère
-
Contato:
- Alexandra BENACHI
- Número de telefone: +33145374476
- E-mail: alexandra.benachi@aphp.fr
-
Investigador principal:
- Alexandra BENACHI
-
-
Paris
-
Paris, Paris, França, 75014
- Hôpital Paris Saint Joseph
-
Investigador principal:
- Elie AZRIA
-
Contato:
- Elie AZRIA
- Número de telefone: +33144127570
- E-mail: eazria@hpsj.fr
-
Paris, Paris, França, 75014
- Hôpital Cochin - Port Royal
-
Investigador principal:
- Vassilis TSATSARIS
-
Contato:
- Vassilis TSATSARIS
- Número de telefone: +33158413871
- E-mail: vassilis.tsatsaris@cch.aphp.fr
-
Paris, Paris, França, 75015
- Hôpital européen Georges-Pompidou
-
Contato:
- Rosa-Maria BRUNO
- Número de telefone: +33156093991
- E-mail: rosamaria.bruno@aphp.fr
-
Investigador principal:
- Rosa-Maria BRUNO
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion criteria:
- Pregnant women > 18 years of age
- Singleton pregnancy
- 10th to 40th week of pregnancy
- Patients affiliated with social security or an equivalent scheme
- Signed informed consent
Exclusion criteria:
- Multifoetal pregnancy
- Known allergies to ultrasound gel
- Patient on AME (state medical aid)
- Patient under a legal protection measure: guardianship, curatorship, or judicial safeguard.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Outro: Pregnant women (>18 years of age) between 10-40th week of pregnancy
We will recruit pregnant women (>18 years of age) between 10-40th week of pregnancy. The study design will be cross-sectional with a total recruitment 200 pregnant women, during routine clinical visits.The element under investigation in this study is the use of carotid ultrasound-derived hemodynamic measurements as a surrogate for CO and PVR assessed by transthoracic echocardiography (TTE) in pregnant women. |
Carotid ultrasound and echocardiography will be performed by an expert operator in all participants for comparison with echocardiography. In all participants, a novice operator will also perform carotid ultrasound to assess inter-operator agreement. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Main objective
Prazo: At inclusion visit
|
To evaluate the accuracy of carotid-ultrasound for classifying individuals with very high peripheral vascular resistance (PVR) or not very high PVR during pregnancy, using echocardiography as the standard reference, both performed by an expert operator. |
At inclusion visit
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Evaluation of the agreement between PVR measurements obtained by echocardiography and carotid ultrasound as continuous variables.
Prazo: At inclusion visit
|
Bland Altman analysis to evaluate the agreement between echocardiography and carotid ultrasound-based estimation of PVR on a continuous scale. Mean differences and bias will be calculated. |
At inclusion visit
|
|
Evaluation of the agreement between cardiac output (CO)measurements obtained by echocardiography and carotid ultrasound as continuous variables.
Prazo: At inclusion visit
|
Bland Altman analysis to evaluate the agreement between echocardiography and carotid ultrasound-based estimation of PVR on a continuous scale. Mean differences and bias will be calculated. |
At inclusion visit
|
|
Evaluation of the inter-operator agreement and variability in carotid ultrasound measurement of PVR between an expert operator and a novice operator.
Prazo: At inclusion visit
|
Inter-operator variability between expert and novice operator for carotid ultrasound-based PVR measurement using Bland-Altman analysis and Intraclass Correlation Coefficient (ICC) will be performed. |
At inclusion visit
|
|
Evaluation of the inter-operator agreement and variability in carotid ultrasound measurement of CO between an expert operator and a novice operator.
Prazo: At inclusion visit
|
Inter-operator variability between expert and novice operator for carotid ultrasound-based PVR measurement using Bland-Altman analysis and Intraclass Correlation Coefficient (ICC) will be performed. |
At inclusion visit
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Evaluation of whether pregnant women with very high (>1300 dynes.s.cm-5) PVR during pregnancy (defined using carotid ultrasound) have a higher incidence of adverse pregnancy outcomes (preeclampsia or pre-term birth) compared to pregnant women without.
Prazo: From inclusion visit, up to 7 months maximum (date of delivery)
|
Single clinically adverse pregnancy outcome defined as incidence of either preeclampsia or pre-term birth - Yes/No Association with PVR tested using multivariable logistic regression. |
From inclusion visit, up to 7 months maximum (date of delivery)
|
|
Investigation of whether the agreement between the PVR obtained by echocardiography and carotid ultrasound is acceptable in both healthy and pathological pregnancies.
Prazo: At inclusion visit
|
Absence of significant bias in the Bland-Altman analysis both in healthy and pathological pregnancies. |
At inclusion visit
|
|
Evaluation of the usability of carotid ultrasound in routine maternity setting.
Prazo: At inclusion visit
|
Mean group score from the post experience usability questionnaire |
At inclusion visit
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- APHP260829
- 2026-A01568-43 (Outro identificador: ANSM)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data (IPD) that underlie results in publication could be shared. IPD detailed in the protocol of a planned metaanalysis could be shared
Prazo de Compartilhamento de IPD
Two years after the last publication
Critérios de acesso de compartilhamento IPD
Data sharing must be accepted by the sponsor and the PI based on a scientific project and scientific involvement of the PI team. Collaboration will be fostered. The founder could be involved in the decision. Teams wishing obtain IPD must meet the sponsor and IP team to present scientifics (and commercial) purpose, IPD needed, format of data transmission, and timeframe. Technical feasibility and financial support will be discussed before mandatory contractualization. Processing of shared data must comply with European General Data Protection Regulation (GDPR).
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- CIF
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .